This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 221853 results found since Jan 2013.

Corrigendum to “Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross-sectional analysis in six South African districts” Contraception 116 (2022) 51–58
The authors regret the oversight of table labeling and placement in the manuscript. Particularly, the misrepresentation of Box 1 as Table 6; this is incorrectly labeled, and we sincerely apologize for this oversight. The Table 6 icon at the bottom of page 55 should be placed at the bottom of page 52 as Box 1, and the Table 6 at the top of page 57 should be moved up as Box 1 to page 52, before the results section.
Source: Contraception - September 22, 2023 Category: OBGYN Authors: Kim Jonas, Carl Lombard, Witness Chirinda, Darshini Govindasamy, Tracy McClinton Appollis, Caroline Kuo, Glenda Gray, Roxanne Beauclair, Mireille Cheyip, Catherine Mathews Source Type: research

Viruses, Vol. 15, Pages 1978: Retention in Care and Virological Failure among Adult HIV-Positive Patients on First-Line Antiretroviral Treatment in Maputo, Mozambique
Conclusions: We have identified clinical and sociodemographic determinants of loss to follow-up and in the development of virological failure for HIV-positive patients in clinical care in the MMH. Therefore, HIV programs must consider these factors to increase the screening of patients at high risk of poor outcomes and particularly to strengthen adherence counselling programs.
Source: Viruses - September 22, 2023 Category: Virology Authors: Leonid Joaquim Mafalda N. S. Miranda Victor Pimentel Maria do Rosario Oliveira Martins Tacilta Nhampossa Ana Abecasis Marta Pingarilho Tags: Article Source Type: research

Lack of associations of microRNAs with severe NAFLD in people living with HIV: discovery case-control study
ConclusionAnalysis of the microRNA transcriptome profile of nonobese PLWH with severe NAFLD did not appear to differ from that of patients without NAFLD. Thus, microRNA might not serve as a proper biomarker for predicting severe NALFD in this population.
Source: Frontiers in Endocrinology - September 22, 2023 Category: Endocrinology Source Type: research

Recommendations on data sharing in HIV drug resistance research
by Seth C. Inzaule, Mark J. Siedner, Susan J. Little, Santiago Avila-Rios, Alisen Ayitewala, Ronald J. Bosch, Vincent Calvez, Francesca Ceccherini-Silberstein, Charlotte Charpentier, Diane Descamps, Susan H. Eshleman, Joseph Fokam, Lisa M. Frenkel, Ravindra K. Gupta, John P.A. Ioannidis, Pontiano Kaleebu, Rami Kantor, Seble G. Kassaye, Sergei L. Kosakovsky Pond, Vinie Kouamou, Roger D. Kouyos, Daniel R. Kuritzkes, Richard Lessells, Anne-Genevieve Marcelin, Lawrence Mbuagbaw, Brian Minalga, Nicaise Ndembi, Richard A. Neher, Roger Paredes, Deenan Pillay, Elliot G. Raizes, Soo-Yon Rhee, Douglas D. Richman, Kiat Ruxrungtham, P...
Source: PLoS Medicine - September 22, 2023 Category: Internal Medicine Authors: Seth C. Inzaule Source Type: research

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-25-017 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to: 1.Support mining of SCORCH data to identify cell types, transcripts, enhancers, or transcriptional networks that play a role in HIV/ART or SUD molecular responses 2.Support functional validation studies (e.g. epigenomic or transcriptomic manipulation, high throughput secondary screening, etc.) to confirm or deny a biological role for data-mined cell types, transcripts, enhancers, or transcriptional networks in HIV/ART or SUD molecular responses 3.Provide foundational knowledge for understanding SUD and/or H...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2023 Category: Research Source Type: funding

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-25-016 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to: 1.Support mining of SCORCH data to identify cell types, transcripts, enhancers, or transcriptional networks that play a role in HIV/ART or SUD molecular responses 2.Support functional validation studies (e.g. epigenomic or transcriptomic manipulation, high throughput secondary screening, etc.) to confirm or deny a biological role for data-mined cell types, transcripts, enhancers, or transcriptional networks in HIV/ART or SUD molecular responses 3.Provide foundational knowledge for understanding SUD and/or H...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2023 Category: Research Source Type: funding

Single Source: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-25-015 from the NIH Guide for Grants and Contracts. To establish a Data Center to coordinate and analyze single cell and other molecular data sets generated by Single Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects and to make the data findable, accessible, interoperable, and reusable (FAIR) to enable secondary analyses by the scientific community.
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2023 Category: Research Source Type: funding

The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Conditions:   Hiv;   AIDS;   CD4 Deficiency;   ART;   Treatment Resistant Disorders;   Treatment-Sensitive HIV Infection Intervention:   Other: differences in CD4 reconstruction Sponsor:   Medical University of Warsaw Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Predictors of Health Service Utilizations Among Key Population in Washington DC
Conditions:   Pre-exposure Prophylaxis;   HIV;   Health Behavior Intervention:   Sponsor:   Us Helping Us, People Into Living, Inc. Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
Conditions:   Monkeypox;   HIV Infections;   AIDS Intervention:   Sponsor:   Centers for Disease Control and Prevention Recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Predictors of Health Service Utilizations Among Key Population in Washington DC
Conditions:   Pre-exposure Prophylaxis;   HIV;   Health Behavior Intervention:   Sponsor:   Us Helping Us, People Into Living, Inc. Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
Conditions:   Monkeypox;   HIV Infections;   AIDS Intervention:   Sponsor:   Centers for Disease Control and Prevention Recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)
Conditions:   HIV;   HIV Pre-exposure Prophylaxis Interventions:   Drug: MK-8527;   Drug: Placebo to MK-8527 Sponsor:   Merck Sharp & Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials